‘Crisis of Its Own Creation’: Activist JANA Blasts Cooper, Demands CEO Search

Bausch + Lomb Receives FDA Warning Letter Over Sterile Drug Manufacturing At Tampa Plant, Citing Inadequate Aseptic Controls And Persistent Microbial Contamination; Products Deemed Adulterated

https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bausch-lomb-inc-732398-09042026

Needham Reiterates Hold on Bausch & Lombto Hold

Needham analyst David Saxon reiterates Bausch & Lomb (NYSE:BLCO) from Hold to Hold.

Leerink Partners Initiates Coverage On Bausch & Lomb with Outperform Rating, Announces Price Target of $24

Leerink Partners analyst Daniel Clark initiates coverage on Bausch & Lomb (NYSE:BLCO) with a Outperform rating and announces Price Target of $24.

Cooper Companies shares are trading higher after activist investor JANA Partners sent a letter to the company's board demanding that it undertake an external search for a new CEO, appoint a new Board chair and consider asset sales.

JANA Partners Calls For Cooper Companies Board To Commence Immediate External CEO Search, Appoint New Board Chair And Evaluate Asset Sales

JANA Partners ("JANA") today announced that it has sent a letter to the Board of Directors (the "Board") of The Cooper Companies, Inc. (NASDAQ:COO) ("Cooper" or the "Company")

The Wall Street Journal Reported Jana Partners Wants Contact-Lens Maker Cooper Cos. To Replace The CEO, Citing Letter

https://www.wsj.com/business/deals/jana-partners-pushes-contact-lens-maker-cooper-to-replace-its-ceo-4a6f74ad?eafs_enabled=false